THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.
Adult glioblastoma
Paediatric high-grade glioma
EU initiative for understanding cancer
Magnetic resonance imaging
Standard of care
Immuno-oncology
Tumour treating fields
accelopment Schweiz AG (accelCH) is a Swiss SME that assists research institutions and companies in EU proposal writing, EU project management and the dissemination and exploitation of results.
It is specialised in European research and innovation support initiatives, such as Horizon Europe and the SME focused Eurostars programme. accelCH’s multi-disciplinary and highly qualified staff has over 25 years of experience in EU and national funded projects in Health, Biochemistry, Energy, ICT, Materials and other areas. Since its foundation in 2008, accelCH has collaborated with more than 1,000 organisations in Europe and beyond, starting with the 7th Framework Programme and continuing into Horizon 2020 and Horizon Europe. accelCH is ISO 9001 certified and internationally accredited by IQnet and members of the Swiss Association for Quality and Management Systems.
What is accelCH’s main role?
Providing EU project management support
Planning and Implementing stakeholder involvement, communication, dissemination and exploitation measures
Supporting innovation management activities
Advising on EU project finances
Which work packages is accelCH involved in?
See our dedicated page for more details on the GLIOMATCH work plan.
accelCH leads work package 7 and is the co-leader of work package 8
Who represents accelCH?
GLIOMATCH Partners